Menu
Recruiting NCT06201884

Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery

Phase II Interventional Oncology Elderly Patients Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Early rehabilitation through Adapted Physical Activity.
Who it may be relevant to
Registry conditions: Oncology, Elderly Patients, Surgery. Basic parameters: from 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of this study was to evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older.

Interventions

  • Device Early rehabilitation through Adapted Physical Activity
    From the day after surgery, 1 to 2 walking sessions with walking platform, lasting 6 to 30 minutes (min-max), will be proposed daily until the day of discharge.

Primary outcome measures

  • To evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older. [Time frame: at hospital discharge (approximately 15 to 30 days after surgery)]

Eligibility criteria

Inclusion criteria

  • Men or women aged 65 or over
  • Candidate for scheduled major oncological surgery and/or surgery with high morbidity
  • Patient able to walk for 10 minutes on the walking platform at the time of the test
  • Patient affiliated to a social security system
  • Signature of informed consent prior to any specific study-related procedure

Exclusion criteria

  • Patient with severe undernutrition (BMI<18, and/or weight loss >15% in 6 months or >10% in 1 month)
  • Emergency surgery
  • Physical contraindications preventing use of the platform
  • Simultaneous participation in another clinical study that could compromise the conduct of this study
  • Patients deprived of their liberty, under guardianship or subject to a legal protection measure, or unable to express their consent.
  • Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

France · 2 centers
  • Centre Francois Baclesse — Caen
  • CHU CAEN — Caen

Identifiers

NCT: NCT06201884 · 2023-A01292-43

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗